Gyeonggi, South Korea

Cheon-Ju Kim

This inventor holds 2 USPTO granted patents. Top assignee: Cheiljedang Corp.. Active years: 2006-2007.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Cheon-Ju Kim: Innovator in Microbial Production of L-Glutamine

Introduction

Cheon-Ju Kim is a notable inventor based in Kyunggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of amino acids through novel microorganisms. His work has led to the development of innovative processes that enhance yield and efficiency.

Latest Patents

Cheon-Ju Kim holds 2 patents related to microorganisms and processes for producing L-glutamine. His latest patents introduce novel microorganisms, CJJA21 (Accession No. KCCM-10222) and CJJA22 (Accession No. KCCM-10223), which exhibit resistance to sodium azide and α-aminobutyric acid, respectively. These microorganisms are capable of producing L-glutamine in higher yields compared to previously known strains. The patents also detail processes for utilizing these microorganisms to optimize L-glutamine production.

Career Highlights

Cheon-Ju Kim is associated with Cheiljedang Corporation, a leading company in the food and biotechnology sectors. His work at the company has been instrumental in advancing microbial technologies for amino acid production.

Collaborations

He has collaborated with notable colleagues, including Sung-Sik Park and Seung-Hyun Suh, to further enhance the research and development of microbial processes.

Conclusion

Cheon-Ju Kim's innovative work in the field of biotechnology, particularly in the production of L-glutamine, showcases his commitment to advancing microbial technology. His contributions are paving the way for more efficient production methods in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…